MedPath

Prevalence and Variables Associated With Depression in Subjects With Chronic Wounds Using PHQ-9 as a Screening Tool

Conditions
Wound
Registration Number
NCT04701632
Lead Sponsor
Methodist Health System
Brief Summary

The objective of the study is to complete a retrospective chart review of subjects who were treated at the Wound Care Clinic at Methodist Dallas Medical Center, presented for treatment between June 2018 and February 2019, and were administered the PHQ-9. The study aims to measure the prevalence of depression in this sample, feasibility of using PHQ-9 in this patient population, and identifying variables and functional impairment associated with clinically significant depression.

Detailed Description

The study will review medical records of new patients who presented to the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019. These patients were all administered PHQ-9 as part of a quality improvement project. The medical records included for analysis will be from male and female patients aged 18 years or older. The medical records will be reviewed for the following information: general demographics, information including age, sex, ethnicity, race, PHQ-9 score (total and individual items), medical conditions, wound history, past medical history, general symptoms, abuse and suicide risk, activities of daily living, motivation assessment, mental status, and pain ratings. This information will be used to measure the prevalence of clinically significant depression in the sample, which is the primary aim. We will also use the data to establish factors and variables correlated with the presence and severity of clinically significant depression.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  1. Age 18 or older
  2. Received care at the Wound Care Center at Methodist Dallas Medical Center between June 2018 and February 2019
  3. Completed a PHQ-9 form at the time of initial evaluation/examination
Exclusion Criteria
  1. Patients less than 18 years of age will be excluded from the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PHQ-9 scoreThrough study completion, an average of 1 year

to measure the prevalence of clinically significant depression defined as a PHQ-9 score of equal to or greater than 10.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wound care & Hyperbaric Clinic

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath